Protalix Biotherapeutics, Inc. current report, Q2 FY2012

Vollständiges Dokument

Business Context and Reporting Period

Company: Protalix Biotherapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 29, 2012
Context: The filing serves as a Regulation FD disclosure to announce upcoming corporate presentations by senior management at three major healthcare conferences in June 2012.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding conference schedules and does not contain financial statements or performance data.

Material Changes

No material changes to financial position or operations are reported in this document. The filing solely discloses the schedule of upcoming investor relations events.

Guidance, Outlook, and Management Commentary

Upcoming Presentations:

  • Jefferies 2012 Global Healthcare Conference: June 4, 2012, 1:30 PM EDT. Presenter: Yossi Maimon, CFO. Webcast available.
  • 2012 BIO International Convention: June 19, 2012. Presenter: Dr. David Aviezer, CEO. Includes a session on biomanufacturing challenges and a corporate presentation.
  • Wells Fargo Securities Research & Economics 2012 Healthcare Conference: June 20, 2012, 9:30 AM EDT. Presenter: Dr. David Aviezer, CEO. Webcast available.
Legal Disclaimer: The information contained in this report and the accompanying press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Verify the availability of webcast replays on the company website (www.protalix.com) within 30 days of the events.
  • Confirm the specific dates and times for the three announced conferences to ensure attendance or viewing.
  • Note that this filing contains no financial data; investors should refer to the most recent 10-Q or 10-K for financial metrics.